Form D — Sensorium Therapeutics, Inc.
0001874823-25-000001 · filed Feb 12, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $38,496,525
- Reported amount sold
- $14,496,526
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Sensorium Therapeutics, Inc.
- CIK
- 1874823
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 47 HIGH ST. #513
MEDFORD, MA 02155 - Phone
- (339) 329-2333
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexandra Glucksmann · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Richard Simon · DirectorBoston, MA Find on LinkedIn ↗
-
Jerrold Rosenbaum · DirectorBoston, MA Find on LinkedIn ↗
-
Kevin Lalande · DirectorBoston, MA Find on LinkedIn ↗
-
Ryan Katz · DirectorBoston, MA Find on LinkedIn ↗
-
David Southwell · DirectorBoston, MA Find on LinkedIn ↗
-
Balkrishan Gill · DirectorBoston, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗